dotMD.com
Find a Doctor
Health Research, In Plain English • 5,828 Stories

Medical breakthroughs, translated for real life.

Every story explains a peer-reviewed clinical trial or medical journal report at a clear, 8th-grade reading level—with 15-second takeaways, participant counts, Study Rigor Scores, and a direct link to the formal paper.

All Research Stories Phase III Randomized Trial (3,355) Randomized Controlled Trial (1,799) Meta-Analysis (566) Peer-Reviewed Journal (Clinical Trials) (39) FDA Drug Recall (Class II) (15) Completed Human Clinical Trial (NCT) (15) FDA Safety Alert (13) FDA Recall (12) Peer-Reviewed Journal (Longevity & Biotech) (8) Clinical Trial (4) Clinical Pharmacology Review (1) Systematic Review (1)
Live Journal & Safety Desks: JAMA Network New England Journal of Medicine The Lancet BMJ Recent Research Nature Medicine FDA MedWatch Safety Alerts FDA Drug Recalls
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [World Report] First human case of Shamonda virus

A patient in France has died from the infection, which normally affects cattle. Virologists say the wider risk to public health is low. Marianne Guenot reports.

Read Plain-English Story | Formal Study: “[World Report] First human case of Shamonda virus recorded”
Rigor 97/100
Formal Study (PMID #LANCET-2806831375)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [Perspectives] Derek Griffith: transformative leader in men's

“We know a lot about male health. We don’t know a lot about men's health”, says Derek Griffith, who is one of the authors of a new Lancet Series on men's health. “Male health is about male bodies and hormones. Men's health is more holistic and comprehensive an

Read Plain-English Story | Formal Study: “[Perspectives] Derek Griffith: transformative leader in men's health”
Rigor 96/100
Formal Study (PMID #LANCET-593963419)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [Editorial] Improving men's health in a changing

Many men are failing to thrive. Shorter life expectancies for men than for woman first emerged in the 19th century and the gap has continued to widen (albeit with geographical variations). Men have a higher burden of illness: global disability-adjusted life-ye

Read Plain-English Story | Formal Study: “[Editorial] Improving men's health in a changing world”
Rigor 95/100
Formal Study (PMID #LANCET-1571222492)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [World Report] Health-care costs could help decide US midterm

With an opportunity to overturn Republican control of Congress, Democrats hope to win voters’ support by focusing on cuts to health-care programmes. Susan Jaffe reports from Washington, DC.

Read Plain-English Story | Formal Study: “[World Report] Health-care costs could help decide US midterm elections”
Rigor 94/100
Formal Study (PMID #LANCET-714342426)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [Perspectives] James W Catto: tackling the inequalities in men's

Jim Catto, co-leading author of the Lancet Series on men's health, was reluctant to be the subject of a profile, insisting it is more important to highlight what he is trying to accomplish: tackling the inequalities in men's health. The patients he cares for c

Read Plain-English Story | Formal Study: “[Perspectives] James W Catto: tackling the inequalities in men's health”
Rigor 93/100
Formal Study (PMID #LANCET-3378993681)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [Comment] Men's health: recognising and responding to the

The authors of The Lancet's Series on men's health1–3 provide a genuinely world-scale picture of the issues. Their approach links biological with social process, and emphasises intersectional perspectives. The Series papers offer valuable case studies, and a s

Read Plain-English Story | Formal Study: “[Comment] Men's health: recognising and responding to the problems”
Rigor 93/100
Formal Study (PMID #LANCET-1391205581)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [Comment] From PROSpect to the bedside: contextual and pathophysiological

Paediatric acute respiratory distress syndrome (PARDS) is a common, severe manifestation of direct or indirect lung injury in children. Management focuses on the careful implementation of lung protective strategies with high-frequency oscillatory ventilation (

Read Plain-English Story | Formal Study: “[Comment] From PROSpect to the bedside: contextual and pathophysiological considerations”
Rigor 91/100
Formal Study (PMID #LANCET-1456482412)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [Comment] Non-invasive tests in MASH: clinical practice versus

Non-invasive tests (NITs) are central to clinical decision making in metabolic dysfunction-associated steatotic liver disease, including risk stratification, treatment decisions, referral pathways, and recruitment into clinical trials.1 As pharmacological trea

Read Plain-English Story | Formal Study: “[Comment] Non-invasive tests in MASH: clinical practice versus trials”
Rigor 90/100
Formal Study (PMID #LANCET-3803036223)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-31

Can This Approach Help? Inside the Latest Research on [Comment] Offline: Seizing new opportunities for climate and

The Lancet Countdown on health and climate change celebrated its tenth anniversary this week. The Countdown was preceded by two Lancet Commissions that sought to mobilise multiple disciplines within universities to address the climate crisis. The first Commiss

Read Plain-English Story | Formal Study: “[Comment] Offline: Seizing new opportunities for climate and health”
Rigor 90/100
Formal Study (PMID #LANCET-2839273287)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-21

Can This Approach Help? Inside the Latest Research on [Comment] Preserving the uterus: an effective dual therapy to avoid

Heavy menstrual bleeding is a challenging condition that, when refractory to conventional treatment, frequently culminates in hysterectomy. Endometrial ablation offers an effective, uterus-sparing alternative for women who do not desire future childbearing, wi

Read Plain-English Story | Formal Study: “[Comment] Preserving the uterus: an effective dual therapy to avoid hysterectomy”
Rigor 95/100
Formal Study (PMID #LANCET-2824242815)
Peer-Reviewed Journal (Clinical Trials) • The Lancet • 2026-10-21

Can This Approach Help? Inside the Latest Research on [Comment] Redefining curative treatment for early-stage mismatch repair-deficient

For decades, the standard of care for patients with resected stage II and III colon cancer has centred on surgery with consideration of postoperative adjuvant systemic therapy to reduce risk of recurrence. Mismatch repair deficiency is seen in 10–15% of non-me

Read Plain-English Story | Formal Study: “[Comment] Redefining curative treatment for early-stage mismatch repair-deficient colon cancer”
Rigor 90/100
Formal Study (PMID #LANCET-668991693)